Mr Dr Matthew Worthley
Interventional Cardiologist and Director of Cardiology, Royal Adelaide Hospital
Research Fellow, South Australian Health and Medical Research Institute (SAHMRI)
Associate Professor, University of Adelaide
Convenor of Advanced Training, Royal Australasian College of Physicians
Board Member, Cardiac Society of Australia and New Zealand
Cardiovascular disease remains a major cause of morbidity and mortality in renal transplant recipients. Identifying myocardial ischaemia in asymptomatic individuals prior to renal transplantation remains a contentious issue. This talk plans to summarise the evidence which established a South Australian myocardial ischaemia screening program prior to renal transplantation along with the outcomes of this program. Finally this talk will also discuss new evidence which questions the benefits of myocardial ischaemia screening and how this has modified this screening process in South Australia.